{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T01:46:41Z","timestamp":1769737601046,"version":"3.49.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Metab"],"DOI":"10.1038\/s42255-025-01439-y","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T10:03:01Z","timestamp":1768989781000},"page":"177-195","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["IL-21 mediates crosstalk between T cells and NK cells during the remission of type 1 diabetes"],"prefix":"10.1038","volume":"8","author":[{"given":"Kang","family":"Lei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5934-7816","authenticated-orcid":false,"given":"Qiaolin","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6682-7372","authenticated-orcid":false,"given":"Paul E.","family":"Love","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiguang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4302-2333","authenticated-orcid":false,"given":"Bin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8665-7983","authenticated-orcid":false,"given":"Xia","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,21]]},"reference":[{"key":"1439_CR1","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41574-024-01029-0","volume":"21","author":"A Grattoni","year":"2025","unstructured":"Grattoni, A. et al. Harnessing cellular therapeutics for type 1 diabetes mellitus: progress, challenges, and the road ahead. Nat. Rev. Endocrinol. 21, 14\u201330 (2025).","journal-title":"Nat. Rev. Endocrinol."},{"key":"1439_CR2","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1126\/science.abh1654","volume":"373","author":"JA Bluestone","year":"2021","unstructured":"Bluestone, J. A., Buckner, J. H. & Herold, K. C. Immunotherapy: building a bridge to a cure for type 1 diabetes. Science 373, 510\u2013516 (2021).","journal-title":"Science"},{"key":"1439_CR3","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1056\/NEJMoa1902226","volume":"381","author":"KC Herold","year":"2019","unstructured":"Herold, K. C. et al. An anti-CD3 antibody, teplizumab, in relatives at risk for type 1 diabetes. N. Engl. J. Med. 381, 603\u2013613 (2019).","journal-title":"N. Engl. J. Med."},{"key":"1439_CR4","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.cmet.2019.11.017","volume":"31","author":"JT Warshauer","year":"2020","unstructured":"Warshauer, J. T., Bluestone, J. A. & Anderson, M. S. New frontiers in the treatment of type 1 diabetes. Cell Metab. 31, 46\u201361 (2020).","journal-title":"Cell Metab."},{"key":"1439_CR5","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.141814","volume":"6","author":"Y Xiao","year":"2021","unstructured":"Xiao, Y. et al. Fatty acid binding protein 4 promotes autoimmune diabetes by recruitment and activation of pancreatic islet macrophages. JCI Insight 6, e141814 (2021).","journal-title":"JCI Insight"},{"key":"1439_CR6","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/ni.1834","volume":"11","author":"C Gur","year":"2010","unstructured":"Gur, C. et al. The activating receptor NKp46 is essential for the development of type 1 diabetes. Nat. Immunol. 11, 121\u2013128 (2010).","journal-title":"Nat. Immunol."},{"key":"1439_CR7","doi-asserted-by":"publisher","first-page":"611522","DOI":"10.3389\/fimmu.2020.611522","volume":"11","author":"L Gomez-Mu\u00f1oz","year":"2020","unstructured":"Gomez-Mu\u00f1oz, L. et al. NK cell subsets changes in partial remission and early stages of pediatric type 1 diabetes. Front. Immunol. 11, 611522 (2020).","journal-title":"Front. Immunol."},{"key":"1439_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2020.102417","volume":"108","author":"JW Dean","year":"2020","unstructured":"Dean, J. W. et al. Innate inflammation drives NK cell activation to impair Treg activity. J. Autoimmun. 108, 102417 (2020).","journal-title":"J. Autoimmun."},{"key":"1439_CR9","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abd5666","volume":"13","author":"LP Xhonneux","year":"2021","unstructured":"Xhonneux, L. P. et al. Transcriptional networks in at-risk individuals identify signatures of type 1 diabetes progression. Sci. Transl. Med. 13, eabd5666 (2021).","journal-title":"Sci. Transl. Med."},{"key":"1439_CR10","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.immuni.2004.05.008","volume":"20","author":"K Ogasawara","year":"2004","unstructured":"Ogasawara, K. et al. NKG2D blockade prevents autoimmune diabetes in NOD mice. Immunity 20, 757\u2013767 (2004).","journal-title":"Immunity"},{"key":"1439_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0036011","volume":"7","author":"JN Beilke","year":"2012","unstructured":"Beilke, J. N. et al. NK cells are not required for spontaneous autoimmune diabetes in NOD mice. PLoS ONE 7, e36011 (2012).","journal-title":"PLoS ONE"},{"key":"1439_CR12","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/s41577-023-00985-4","volume":"24","author":"KC Herold","year":"2024","unstructured":"Herold, K. C. et al. The immunology of type 1 diabetes. Nat. Rev. Immunol. 24, 435\u2013451 (2024).","journal-title":"Nat. Rev. Immunol."},{"key":"1439_CR13","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1038\/s41590-024-01883-0","volume":"25","author":"L Rebuffet","year":"2024","unstructured":"Rebuffet, L. et al. High-dimensional single-cell analysis of human natural killer cell heterogeneity. Nat. Immunol. 25, 1474\u20131488 (2024).","journal-title":"Nat. Immunol."},{"key":"1439_CR14","doi-asserted-by":"publisher","first-page":"4235","DOI":"10.1016\/j.cell.2023.07.034","volume":"186","author":"F Tang","year":"2023","unstructured":"Tang, F. et al. A pan-cancer single-cell panorama of human natural killer cells. Cell 186, 4235\u20134251.e20 (2023).","journal-title":"Cell"},{"key":"1439_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3207","volume":"36","author":"T Zhong","year":"2020","unstructured":"Zhong, T. et al. The remission phase in type 1 diabetes: changing epidemiology, definitions, and emerging immuno-metabolic mechanisms. Diabetes Metab. Res. Rev. 36, e3207 (2020).","journal-title":"Diabetes Metab. Res. Rev."},{"key":"1439_CR16","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.tem.2023.10.005","volume":"35","author":"L Gomez-Mu\u00f1oz","year":"2024","unstructured":"Gomez-Mu\u00f1oz, L., Dominguez-Bendala, J., Pastori, R. L. & Vives-Pi, M. Immunometabolic biomarkers for partial remission in type 1 diabetes mellitus. Trends Endocrinol. Metab. 35, 151\u2013163 (2024).","journal-title":"Trends Endocrinol. Metab."},{"key":"1439_CR17","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa130","volume":"105","author":"X Li","year":"2020","unstructured":"Li, X. et al. PD-1 and PD-L1 Expression in peripheral CD4\/CD8+ T cells is restored in the partial remission phase in type 1 diabetes. J. Clin. Endocrinol. Metab. 105, dgaa130 (2020).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1439_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2024.103171","volume":"143","author":"T Zhong","year":"2024","unstructured":"Zhong, T. et al. CXCL12\u2013CXCR4 mediates CD57+ CD8+ T cell responses in the progression of type 1 diabetes. J. Autoimmun. 143, 103171 (2024).","journal-title":"J. Autoimmun."},{"key":"1439_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-53264-8","volume":"15","author":"T Zhong","year":"2024","unstructured":"Zhong, T. et al. TGF-\u03b2-mediated crosstalk between TIGIT+ Tregs and CD226+CD8+ T cells in the progression and remission of type 1 diabetes. Nat. Commun. 15, 8894 (2024).","journal-title":"Nat. Commun."},{"key":"1439_CR20","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.immuni.2018.09.009","volume":"49","author":"A Crinier","year":"2018","unstructured":"Crinier, A. et al. High-dimensional single-cell analysis identifies organ-specific signatures and conserved NK cell subsets in humans and mice. Immunity 49, 971\u2013986.e5 (2018).","journal-title":"Immunity"},{"key":"1439_CR21","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.3389\/fimmu.2019.01812","volume":"10","author":"C Di Vito","year":"2019","unstructured":"Di Vito, C., Mikulak, J. & Mavilio, D. On the way to become a natural killer cell. Front. Immunol. 10, 1812 (2019).","journal-title":"Front. Immunol."},{"key":"1439_CR22","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1126\/science.aax0249","volume":"367","author":"GS Gulati","year":"2020","unstructured":"Gulati, G. S. et al. Single-cell transcriptional diversity is a hallmark of developmental potential. Science 367, 405\u2013411 (2020).","journal-title":"Science"},{"key":"1439_CR23","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abl4414","volume":"15","author":"G Thacker","year":"2023","unstructured":"Thacker, G. et al. Immature natural killer cells promote progression of triple-negative breast cancer. Sci. Transl. Med. 15, eabl4414 (2023).","journal-title":"Sci. Transl. Med."},{"key":"1439_CR24","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20192362","volume":"217","author":"PN Zakharov","year":"2020","unstructured":"Zakharov, P. N., Hu, H., Wan, X. & Unanue, E. R. Single-cell RNA sequencing of murine islets shows high cellular complexity at all stages of autoimmune diabetes. J. Exp. Med. 217, e20192362 (2020).","journal-title":"J. Exp. Med."},{"key":"1439_CR25","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1038\/s41592-021-01274-5","volume":"18","author":"P Jiang","year":"2021","unstructured":"Jiang, P. et al. Systematic investigation of cytokine signaling activity at the tissue and single-cell levels. Nat. Methods 18, 1181\u20131191 (2021).","journal-title":"Nat. Methods"},{"key":"1439_CR26","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/nri3799","volume":"15","author":"L Martinet","year":"2015","unstructured":"Martinet, L. & Smyth, M. J. Balancing natural killer cell activation through paired receptors. Nat. Rev. Immunol. 15, 243\u2013254 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"1439_CR27","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.immuni.2022.12.010","volume":"56","author":"D Briukhovetska","year":"2023","unstructured":"Briukhovetska, D. et al. T cell-derived interleukin-22 drives the expression of CD155 by cancer cells to suppress NK cell function and promote metastasis. Immunity 56, 143\u2013161.e11 (2023).","journal-title":"Immunity"},{"key":"1439_CR28","doi-asserted-by":"publisher","DOI":"10.1172\/JCI146408","volume":"131","author":"WC Hsieh","year":"2021","unstructured":"Hsieh, W. C. et al. NK cell receptor and ligand composition influences the clearance of SARS-CoV-2. J. Clin. Invest. 131, e146408 (2021).","journal-title":"J. Clin. Invest."},{"key":"1439_CR29","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.celrep.2015.03.006","volume":"11","author":"L Martinet","year":"2015","unstructured":"Martinet, L. et al. DNAM-1 expression marks an alternative program of NK cell maturation. Cell Rep. 11, 85\u201397 (2015).","journal-title":"Cell Rep."},{"key":"1439_CR30","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1182\/bloodadvances.2018030676","volume":"3","author":"KA Stannard","year":"2019","unstructured":"Stannard, K. A. et al. Human peripheral blood DNAM-1neg NK cells are a terminally differentiated subset with limited effector functions. Blood Adv. 3, 1681\u20131694 (2019).","journal-title":"Blood Adv."},{"key":"1439_CR31","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1016\/j.cell.2020.02.029","volume":"180","author":"A Crinier","year":"2020","unstructured":"Crinier, A., Narni-Mancinelli, E., Ugolini, S. & Vivier, E. SnapShot: natural killer cells. Cell 180, 1280\u20131280.e1 (2020).","journal-title":"Cell"},{"key":"1439_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01827-6","volume":"22","author":"A Glaviano","year":"2023","unstructured":"Glaviano, A. et al. PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer. Mol. Cancer 22, 138 (2023).","journal-title":"Mol. Cancer"},{"key":"1439_CR33","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/s41423-021-00780-y","volume":"19","author":"WC Chou","year":"2022","unstructured":"Chou, W. C., Rampanelli, E., Li, X. & Ting, J. P. Impact of intracellular innate immune receptors on immunometabolism. Cell. Mol. Immunol. 19, 337\u2013351 (2022).","journal-title":"Cell. Mol. Immunol."},{"key":"1439_CR34","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nri3198","volume":"12","author":"H Chi","year":"2012","unstructured":"Chi, H. Regulation and function of mTOR signalling in T cell fate decisions. Nat. Rev. Immunol. 12, 325\u2013338 (2012).","journal-title":"Nat. Rev. Immunol."},{"key":"1439_CR35","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1002\/hep.21419","volume":"44","author":"WI Jeong","year":"2006","unstructured":"Jeong, W. I., Park, O., Radaeva, S. & Gao, B. STAT1 inhibits liver fibrosis in mice by inhibiting stellate cell proliferation and stimulating NK cell cytotoxicity. Hepatology 44, 1441\u20131451 (2006).","journal-title":"Hepatology"},{"key":"1439_CR36","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1182\/blood-2014-03-564450","volume":"124","author":"D Gotthardt","year":"2014","unstructured":"Gotthardt, D. et al. Loss of STAT3 in murine NK cells enhances NK cell-dependent tumor surveillance. Blood 124, 2370\u20132379 (2014).","journal-title":"Blood"},{"key":"1439_CR37","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.2337\/db08-0882","volume":"58","author":"AP Sutherland","year":"2009","unstructured":"Sutherland, A. P. et al. Interleukin-21 is required for the development of type 1 diabetes in NOD mice. Diabetes 58, 1144\u20131155 (2009).","journal-title":"Diabetes"},{"key":"1439_CR38","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1007\/s00125-015-3509-8","volume":"58","author":"RC Ferreira","year":"2015","unstructured":"Ferreira, R. C. et al. IL-21 production by CD4+ effector T cells and frequency of circulating follicular helper T cells are increased in type 1 diabetes patients. Diabetologia 58, 781\u2013790 (2015).","journal-title":"Diabetologia"},{"key":"1439_CR39","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jaut.2017.07.006","volume":"84","author":"AK Ryd\u00e9n","year":"2017","unstructured":"Ryd\u00e9n, A. K. et al. Anti-IL-21 monoclonal antibody combined with liraglutide effectively reverses established hyperglycemia in mouse models of type 1 diabetes. J. Autoimmun. 84, 65\u201374 (2017).","journal-title":"J. Autoimmun."},{"key":"1439_CR40","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/S2213-8587(21)00019-X","volume":"9","author":"M von Herrath","year":"2021","unstructured":"von Herrath, M. et al. Anti-interleukin-21 antibody and liraglutide for the preservation of \u03b2-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Diabetes Endocrinol. 9, 212\u2013224 (2021).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"1439_CR41","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.immuni.2012.04.005","volume":"36","author":"TL Van Belle","year":"2012","unstructured":"Van Belle, T. L., Nierkens, S., Arens, R. & von Herrath, M. G. Interleukin-21 receptor-mediated signals control autoreactive T cell infiltration in pancreatic islets. Immunity 36, 1060\u20131072 (2012).","journal-title":"Immunity"},{"key":"1439_CR42","doi-asserted-by":"publisher","first-page":"e003995","DOI":"10.1136\/jitc-2021-003995","volume":"10","author":"CL Duurland","year":"2022","unstructured":"Duurland, C. L. et al. CD161 expression and regulation defines rapidly responding effector CD4+ T cells associated with improved survival in HPV16-associated tumors. J. Immunother. Cancer 10, e003995 (2022).","journal-title":"J. Immunother. Cancer"},{"key":"1439_CR43","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1084\/jem.20081712","volume":"206","author":"MA Kleinschek","year":"2009","unstructured":"Kleinschek, M. A. et al. Circulating and gut-resident human Th17 cells express CD161 and promote intestinal inflammation. J. Exp. Med. 206, 525\u2013534 (2009).","journal-title":"J. Exp. Med."},{"key":"1439_CR44","doi-asserted-by":"publisher","first-page":"5247","DOI":"10.4049\/jimmunol.176.9.5247","volume":"176","author":"R Liu","year":"2006","unstructured":"Liu, R. et al. Autoreactive T cells mediate NK cell degeneration in autoimmune disease. J. Immunol. 176, 5247\u20135254 (2006).","journal-title":"J. Immunol."},{"key":"1439_CR45","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/35040504","volume":"408","author":"J Parrish-Novak","year":"2000","unstructured":"Parrish-Novak, J. et al. Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature 408, 57\u201363 (2000).","journal-title":"Nature"},{"key":"1439_CR46","doi-asserted-by":"publisher","DOI":"10.1172\/JCI178602","volume":"134","author":"M Seyedsadr","year":"2024","unstructured":"Seyedsadr, M. et al. A pathologically expanded, clonal lineage of IL-21-producing CD4+ T cells drives inflammatory neuropathy. J. Clin. Invest. 134, e178602 (2024).","journal-title":"J. Clin. Invest."},{"key":"1439_CR47","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1084\/jem.20072057","volume":"205","author":"A Suto","year":"2008","unstructured":"Suto, A. et al. Development and characterization of IL-21-producing CD4+ T cells. J. Exp. Med. 205, 1369\u20131379 (2008).","journal-title":"J. Exp. Med."},{"key":"1439_CR48","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.immuni.2020.09.010","volume":"53","author":"M Braun","year":"2020","unstructured":"Braun, M. et al. CD155 on tumor cells drives resistance to immunotherapy by inducing the degradation of the activating receptor CD226 in CD8+ T cells. Immunity 53, 805\u2013823.e15 (2020).","journal-title":"Immunity"},{"key":"1439_CR49","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adx9755","volume":"11","author":"ME Brown","year":"2025","unstructured":"Brown, M. E. et al. Human stem cell-derived \u03b2 cells expressing an optimized CD155 reduce cytotoxic immune cell function for application in type 1 diabetes. Sci. Adv. 11, eadx9755 (2025).","journal-title":"Sci. Adv."},{"key":"1439_CR50","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.2337\/dc24-S002","volume":"47","author":"American Diabetes Association Professional Practice Committee.","year":"2024","unstructured":"American Diabetes Association Professional Practice Committee. Diagnosis and classification of diabetes: standards of care in diabetes\u20142024. Diabetes Care 47, S20\u2013S42 (2024).","journal-title":"Diabetes Care"},{"key":"1439_CR51","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.2337\/dc08-1987","volume":"32","author":"HB Mortensen","year":"2009","unstructured":"Mortensen, H. B. et al. New definition for the partial remission period in children and adolescents with type 1 diabetes. Diabetes Care 32, 1384\u20131390 (2009).","journal-title":"Diabetes Care"},{"key":"1439_CR52","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nbt.4096","volume":"36","author":"A Butler","year":"2018","unstructured":"Butler, A., Hoffman, P., Smibert, P., Papalexi, E. & Satija, R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat. Biotechnol. 36, 411\u2013420 (2018).","journal-title":"Nat. Biotechnol."},{"key":"1439_CR53","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"Korsunsky, I. et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat. Methods 16, 1289\u20131296 (2019).","journal-title":"Nat. Methods"},{"key":"1439_CR54","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1038\/nmeth.4463","volume":"14","author":"S Aibar","year":"2017","unstructured":"Aibar, S. et al. SCENIC: single-cell regulatory network inference and clustering. Nat. Methods 14, 1083\u20131086 (2017).","journal-title":"Nat. Methods"},{"key":"1439_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21246-9","volume":"12","author":"S Jin","year":"2021","unstructured":"Jin, S. et al. Inference and analysis of cell\u2013cell communication using CellChat. Nat. Commun. 12, 1088 (2021).","journal-title":"Nat. Commun."},{"key":"1439_CR56","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/s41467-021-27729-z","volume":"13","author":"GC Linderman","year":"2022","unstructured":"Linderman, G. C. et al. Zero-preserving imputation of single-cell RNA-seq data. Nat. Commun. 13, 192 (2022).","journal-title":"Nat. Commun."},{"key":"1439_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"1439_CR58","doi-asserted-by":"publisher","first-page":"867","DOI":"10.2337\/db10-1157","volume":"60","author":"HM McGuire","year":"2011","unstructured":"McGuire, H. M. et al. Interleukin-21 is critically required in autoimmune and allogeneic responses to islet tissue in murine models. Diabetes 60, 867\u2013875 (2011).","journal-title":"Diabetes"}],"container-title":["Nature Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42255-025-01439-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42255-025-01439-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42255-025-01439-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T13:02:45Z","timestamp":1769691765000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42255-025-01439-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,21]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["1439"],"URL":"https:\/\/doi.org\/10.1038\/s42255-025-01439-y","relation":{},"ISSN":["2522-5812"],"issn-type":[{"value":"2522-5812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,21]]},"assertion":[{"value":"19 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}